Grapes for Gut and Heart Health
(CALGRAM Trial)
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to assess the impact of table grape consumption on gut microbiome, intestinal permeability, systemic inflammation, and vascular function in healthy overweight men and women aged 45-70 years. The main questions it aims to answer are: * Does daily grape intake alter intestinal microbiome composition and intestinal permeability? * Are changes in gut microbiota and intestinal permeability correlated with changes in cardiometabolic risk factors (inflammation, vascular function, lipid profiles)? * Does response to grape intake on gut microbiota, intestinal permeability, cardiometabolic and inflammatory markers differ between men and women? * Are metabolic pathways modified by grape consumption able to explain the link between gut health and cardiometabolic factors? Researchers will compare freeze-dried grape powder to placebo powder to see if grape powder improves cardiometabolic risk factors. Participants will * Consume the powder dissolved in water twice daily for 3 weeks * Follow their usual diet, modified to limit polyphenol-rich foods * Visit the clinic at the beginning and end of the intervention for vascular measurements and blood sample collection * Complete a 3-day 24-hour dietary recall and collect stool sample before each visit
Research Team
Eligibility Criteria
This trial is for healthy overweight men and women aged 45-70 who want to explore the health benefits of grape powder on gut and heart health. Participants should not have major health issues but may have concerns like high blood pressure or arterial stiffness. They must be willing to consume a test product daily and follow their usual diet with some restrictions.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Run-in
Participants limit intake of grapes and other polyphenol-rich foods while following their usual diet
Treatment
Participants consume 48 grams of freeze-dried grape powder or placebo dissolved in water twice daily
Washout
Participants undergo a washout period before crossover to the other intervention
Crossover Treatment
Participants switch to the alternate intervention (grape or placebo) for 3 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Freeze-dried grape powder (Prebiotic)
- Placebo powder (Nutritional Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Davis
Lead Sponsor
Rakesh Dixit
University of California, Davis
Chief Executive Officer since 2024
PhD in Biochemistry and Molecular Biology from the University of California, Davis
Suresh Mahabhashyam
University of California, Davis
Chief Medical Officer since 2020
MD from Bangalore Medical College
California Table Grape Commission
Collaborator